Literature DB >> 21984337

Toll-like receptor-2 and interleukin-6 mediate cardiomyocyte protection from apoptosis during Trypanosoma cruzi murine infection.

Nicolás Eric Ponce1, Roxana Carolina Cano, Eugenio Antonio Carrera-Silva, Ana Paula Lima, Susana Gea, Maria Pilar Aoki.   

Abstract

Local innate immunity plays a key role in initiating and coordinating homeostatic and defense responses in the heart. We have previously reported that the cardiotropic parasite Trypanosoma cruzi, the etiological agent of Chagas disease, protects cardiomyocytes against growth factor deprivation-induced apoptosis. In this study, we investigated cardiomyocyte innate immune response to T. cruzi infection and its role in cellular protection from apoptosis. We found that Toll-like receptor (TLR) 2-expressing cells were strongly increased by the parasite in BALB/c neonatal mouse cardiomyocyte cultures. Using a dominant-negative system, we showed that TLR2 mediated cardiomyocyte survival and the secretion of interleukin (IL) 6, which acted as an essential anti-apoptotic factor. Moreover, IL6 released by infected cells, as well as the recombinant bioactive cytokine, induced the phosphorylation of the signal transducers and activators of transcription-3 (STAT3) in cultured cardiomyocytes. In accord with the in vitro results, during the acute phase of the infection, TLR2 expression increased 2.9-fold and the anti-apoptotic factor Bcl-2 increased 4.5-fold in the cardiac tissue. We have clearly shown a cross-talk between the intrinsic innate response of cardiomyocytes and the pro-survival effect evoked by the parasite.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984337     DOI: 10.1007/s00430-011-0216-z

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  37 in total

1.  Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite.

Authors:  M A Campos; I C Almeida; O Takeuchi; S Akira; E P Valente; D O Procópio; L R Travassos; J A Smith; D T Golenbock; R T Gazzinelli
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

2.  Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi.

Authors:  Christine A Petersen; Katherine A Krumholz; Barbara A Burleigh
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi.

Authors:  Wenda Gao; Miercio A Pereira
Journal:  Int J Parasitol       Date:  2002-02       Impact factor: 3.981

4.  The intracellular parasite Theileria parva protects infected T cells from apoptosis.

Authors:  V T Heussler; J Machado; P C Fernandez; C Botteron; C G Chen; M J Pearse; D A Dobbelaere
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 5.  Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program.

Authors:  Robert M Smith; Sandrine Lecour; Michael N Sack
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

6.  TLR2, TLR4 and TLR9 are differentially modulated in liver lethally injured from BALB/c and C57BL/6 mice during Trypanosoma cruzi acute infection.

Authors:  Eugenio Antonio Carrera-Silva; Carrera-Silva Eugenio Antonio; Roxana Carolina Cano; Cano Roxana Carolina; Natalia Guiñazú; Guiñazu Natalia; Maria Pilar Aoki; Aoki Maria Pilar; Andrea Pellegrini; Pellegrini Andrea; Susana Gea; Gea Susana
Journal:  Mol Immunol       Date:  2008-06-18       Impact factor: 4.407

7.  Importance of TLR2 on hepatic immune and non-immune cells to attenuate the strong inflammatory liver response during Trypanosoma cruzi acute infection.

Authors:  Eugenio Antonio Carrera-Silva; Natalia Guiñazu; Andrea Pellegrini; Roxana Carolina Cano; Alfredo Arocena; Maria Pilar Aoki; Susana Gea
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

8.  Interaction between cFLIP and Itch, a ubiquitin ligase, is obstructed in Trypanosoma cruzi-infected human cells.

Authors:  Eri Murata; Muneaki Hashimoto; Takashi Aoki
Journal:  Microbiol Immunol       Date:  2008-11       Impact factor: 1.955

9.  The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.

Authors:  Ali Ouaissi; Eliane Guilvard; Yves Delneste; Gersende Caron; Giovanni Magistrelli; Nathalie Herbault; Nathalie Thieblemont; Pascale Jeannin
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

Review 10.  Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.

Authors:  Wei Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-14       Impact factor: 4.733

View more
  11 in total

Review 1.  Innate immunity and cardiomyocytes in ischemic heart disease.

Authors:  Li Lin; Anne A Knowlton
Journal:  Life Sci       Date:  2014-01-28       Impact factor: 5.037

2.  Interleukin-6 signalling mediates Galectin-8 co-stimulatory activity of antigen-specific CD4 T-cell response.

Authors:  Julieta Carabelli; Cecilia A Prato; Liliana M Sanmarco; Maria P Aoki; Oscar Campetella; María V Tribulatti
Journal:  Immunology       Date:  2018-07-26       Impact factor: 7.397

Review 3.  Trypanosoma cruzi parasites fight for control of the JAK-STAT pathway by disarming their host.

Authors:  Philipp Stahl; Ralph T Schwarz; Françoise Debierre-Grockiego; Thomas Meyer
Journal:  JAKSTAT       Date:  2015-02-03

4.  Trypanosoma cruzi infection induces the expression of CD40 in murine cardiomyocytes favoring CD40 ligation-dependent production of cardiopathogenic IL-6.

Authors:  Mariela Alejandra Moreno Ayala; Agustina Casasco; Mariela González; Miriam Postan; Ricardo Santiago Corral; Patricia Beatriz Petray
Journal:  Parasitol Res       Date:  2015-11-03       Impact factor: 2.289

5.  IL-6 Improves the Nitric Oxide-Induced Cytotoxic CD8+ T Cell Dysfunction in Human Chagas Disease.

Authors:  Liliana Maria Sanmarco; Laura Marina Visconti; Natalia Eberhardt; Maria Cecilia Ramello; Nicolás Eric Ponce; Natalia Beatriz Spitale; Maria Lola Vozza; Germán Andrés Bernardi; Susana Gea; Angel Ramón Minguez; Maria Pilar Aoki
Journal:  Front Immunol       Date:  2016-12-23       Impact factor: 7.561

6.  Atrial Fibrillation Promotion in a Rat Model of Rheumatoid Arthritis.

Authors:  Hui Dai; Xiaoyu Wang; Shuangli Yin; Yun Zhang; Yu Han; Ning Yang; Jicheng Xu; Li Sun; Yue Yuan; Li Sheng; Yongtai Gong; Yue Li
Journal:  J Am Heart Assoc       Date:  2017-12-21       Impact factor: 5.501

7.  Trypanosoma cruzi Promotes Transcriptomic Remodeling of the JAK/STAT Signaling and Cell Cycle Pathways in Myoblasts.

Authors:  Lindice M Nisimura; Laura L Coelho; Tatiana G de Melo; Paloma de Carvalho Vieira; Pedro H Victorino; Luciana R Garzoni; David C Spray; Dumitru A Iacobas; Sanda Iacobas; Herbert B Tanowitz; Daniel Adesse
Journal:  Front Cell Infect Microbiol       Date:  2020-06-17       Impact factor: 5.293

8.  MyD88 activation in cardiomyocytes contributes to the heart immune response to acute Trypanosoma cruzi infection with no effect on local parasite control.

Authors:  Danni Yohani Santana; Rafael Moysés Salgado; Marina Fevereiro; Rogério Silva do Nascimento; Raissa Fonseca; Niels Olsen Saraiva Câmara; Sabrina Epiphanio; Cláudio Romero Farias Marinho; Maria Luiza Barreto-Chaves; Maria Regina D' Império-Lima; José M Álvarez
Journal:  PLoS Negl Trop Dis       Date:  2018-08-01

9.  Identification of Candidate Signature Genes and Key Regulators Associated With Trypanotolerance in the Sheko Breed.

Authors:  Yonatan Ayalew Mekonnen; Mehmet Gültas; Kefena Effa; Olivier Hanotte; Armin O Schmitt
Journal:  Front Genet       Date:  2019-11-14       Impact factor: 4.599

Review 10.  New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular Diseases.

Authors:  Liliana Maria Sanmarco; Natalia Eberhardt; Nicolás Eric Ponce; Roxana Carolina Cano; Gustavo Bonacci; Maria Pilar Aoki
Journal:  Front Immunol       Date:  2018-01-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.